Introduction
Recently there has been renewed interest in the detection and treatment of hypercholesterolaemia; these being of particular importance in young and middle-aged patients with myocardial infarction [1] . It has lately been shown that, contrary to existing dogma, measurement of serum or plasma cholesterol levels within the first 24 h after infarction is a reliable way to assess prognosis or advise treatment [2] . Moreover, if results of cholesterol analyses were available without undue delay while the patient was still hospitalized in the short-stay coronary care unit, the treatment would be initiated by the specialist cardiologist and the required screening of first-degree relatives visiting the patient might be easier to motivate.
One approach to providing results in a timely manner is to perform analyses closer to the patient [3] . Although cholesterol analyses have been performed in an outpatient clinic [4] , there does not appear to be data on the provision of such assays in a coronary care unit. The Ames Seralyzer is a system, based upon reflectance spectroscopy and use of solid-phase reagents, which has been stated to be convenient and reliable [5] , although not without problems and difficulties [7 and 8] . Little data are available on the performance of cholesterol assays and the system was therefore subjected to a full evaluation in the laboratory under optimal conditions variance [9] figure 1 ; statistical analysis, as advocated by Westgard and Hunt [10] , gave a correlation coefficient of 0"980 and the relationship"
Seralyzer 0"97 comparative method + 0.05.
The mean of the results obtained on the Seralyzer was 6"85 mmol/l and the mean by the comparative method was 7"00 mmol/1, which, by the Wilcoxon matched pairs signed rank test, was significantly higher (p >0"001). [15] . The WHO criterion [13] is that analytical bias should not be more than +5.0%; this was not fulfilled at cholesterol levels of 6" 14 and 6"23 rnmol/1. 
